Filter results by document type and/or working area to find what you're searching for.
Infection and inflammation, innate and adaptive immune response, cells that are involved in the different pathways and what the XN-Series analysers have to do with all this are the topics covered within this article.
Malaria is a detectable, preventable, and curable disease, but the burden on global health is still very high. This SEED article discusses a broad range of aspects, from the latest figures from the World Health Organisation and the Plasmodium life cycle to the limitations of stablished diagnostic tests, and how new technologies, such as the Sysmex XN-31 analyser, can enlighten the way towards malaria elimination.
Abnormal RBC results generate extra workload for laboratories and require careful interpretation to guide treatment options. This white paper describes common RBC diseases, both acquired and hereditary, that are frequently encountered in a routine laboratory, and presents how intelligent interpretation of blood counts and algorithms can help identifying these conditions. Subsequent confirmatory tests lead to improved turn-around times.
During HSCT patients suffer from many critical conditions such as thrombocytopenia or infections, as well as it is necessary to closely monitor the engraftment. This white paper explains how a Sysmex haematology analyser can answer your clinical demands.
When determining a differential diagnosis for ITP, the immature platelet fraction (the percentage of immature platelets within the total platelet count), which can be determined alongside a CBC, has been recognised for some time now as a good indicator.